Skip to main content

Table 1 Number of isolates collected by year from T.E.S.T. Latin America centers, 2004–2015

From: Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial

Country

Number of isolatesa

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2011–2015

2004–2015

Central America

 Guatemala

4

0

172

213

187

531

562

1

0

0

0

159

160

1829

 Honduras

0

0

93

97

0

244

1

0

0

0

0

0

0

435

 Panama

0

1

182

90

205

185

182

0

189

196

195

195

775

1620

Rest of Latin America

 Argentina

450

1064

612

1142

1402

1113

900

199

0

0

0

332

531

7214

 Brazil

83

291

161

236

482

583

20

0

0

0

8

344

352

2208

 Chile

5

228

318

624

446

359

0

0

61

197

217

330

805

2785

 Colombia

0

76

461

122

1176

1072

719

341

166

189

196

182

1074

4700

 Mexico

0

105

1111

1010

1921

1586

1242

94

182

456

193

513

1438

8413

 Venezuela

1

0

181

358

240

574

200

137

0

0

0

318

455

2009

All Latin Americab

543

1765

3661

3899

6059

6434

3982

772

598

1038

809

2373

5590

31,933

  1. aNot all countries in Latin America participated in T.E.S.T. every year
  2. bIncludes all countries in Latin America that participated in T.E.S.T. Individual data for El Salvador, Nicaragua, Jamaica and Puerto Rico not present as contributed isolates in ≤2 years